| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |